News

09/14/2021

Dr. Anna Durbin Appointed CIR Director

Dr. Anna Durbin has been appointed director of the Center for Immunization Research.  Dr. Durbin, a principal investigator at the CIR since 1999, began her term as the Center’s newest director on September 1, 2021.  Previous Director Dr. Ruth Karron stepped down to pursue other career interests, and continues to lead the RSVPed Team team […]

08/13/2021

CDC Recommends COVID-19 Vaccinations for Pregnant People

In a media statement released August 12, 2021: “CDC encourages all pregnant people or people who are thinking about becoming pregnant and those breastfeeding to get vaccinated to protect themselves from COVID-19,” said CDC Director Dr. Rochelle Walensky. “The vaccines are safe and effective, and it has never been more urgent to increase vaccinations as […]

06/24/2021

Global Policies on COVID-19 Vaccination in Pregnancy Vary Widely by Country According to New Online Tracker

Johns Hopkins Project Provides Worldwide Snapshot of Policies Influencing Access to COVID-19 Vaccines for Pregnant and Lactating People Although pregnant people are at elevated risk of severe COVID-19 disease and death, countries around the world vary widely in their policies on COVID vaccination in pregnancy, with 41 countries recommending against it. Ninety-one countries have policies […]

04/28/2021

World Immunization Week 2021

World Immunization Week – celebrated every year in the last week of April – aims to promote the use of vaccines to protect people of all ages against disease. Visit the WHO website for more about this year’s observance.

What you need to know as J&J vaccine administration begins again

In this recent interview, Dr. Kawsar Talaat advises those at greater risk for developing blood clots after vaccine administration to discuss risks and benefits with their health care provider or other trusted person in order to make an informed decision on what vaccine may be best for them.  Full story here…  

03/10/2021

Using the new Johnson & Johnson Covid-19 vaccine to create equity and trust

If the newly-approved one dose Johnson & Johnson COVID-19 vaccine is offered in low-income and minority communities in preference to their Pfizer and Moderna counterparts, will it be perceived as another slight by these communities due to questions surrounding it’s effectiveness?  Public health and bioethics experts Drs. Ruth Karron and Ruth Faden discuss an option […]

Translate »